Yüklüyor......
Neratinib for the Treatment of Early-Stage HER2-Positive Breast Cancer
The treatment of breast cancer has been revolutionized by the development of HER2-targeted treatments for patients who are HER2 positive. The HER2 protein is present at high levels in about 30% of breast cancer patients. These high levels are associated with a greater chance of metastasis, relapse,...
Kaydedildi:
| Yayımlandı: | J Adv Pract Oncol |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Harborside Press
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6570523/ https://ncbi.nlm.nih.gov/pubmed/31249722 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|